Stereotaxis
STXS
58 hedge funds and large institutions have $59.9M invested in Stereotaxis in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 5 closing their positions.
220% more call options, than puts
Call options by funds: $16K | Put options by funds: $5K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
2% less capital invested
Capital invested by funds: $61.1M → $59.9M (-$1.2M)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
2% less funds holding
Funds holding: 59 → 58 (-1)
4.04% less ownership
Funds ownership: 50.95% → 46.91% (-4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$358K |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$282K |
| 3 |
APCM
Arbiter Partners Capital Management
New York
|
+$169K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.95M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$973K |
| 3 |
Two Sigma Advisers
New York
|
-$149K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$130K |
| 5 |
Millennium Management
New York
|
-$127K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $14.4K | +$14.6K | +9,133 | New |
|
52
RhumbLine Advisers
Boston,
Massachusetts
| $10.2K | – | – | – |
|
53
Osaic Holdings
Scottsdale,
Arizona
| $8.86K | +$800 | +500 | +10% |
|
54
UBS Group
Zurich,
Switzerland
| $4.21K | -$3.14K | -1,963 | -42% |
|
55
Wells Fargo
San Francisco,
California
| $1.26K | +$227 | +142 | +22% |
|
56
Simplex Trading
Chicago,
Illinois
| $1K | -$18.6K | -11,612 | -91% |
|
|
APC
57
Aspire Private Capital
Cornelius,
North Carolina
| $316 | – | – | – |
|
58
JP Morgan Chase
New York
| $177 | – | – | – |
|
|
OM
59
Opaleye Management
Boston,
Massachusetts
| – | -$2.95M | -3,074,995 | Closed |
|
|
60
Two Sigma Advisers
New York
| – | -$149K | -97,200 | Closed |
|
|
GCP
61
GSA Capital Partners
London,
United Kingdom
| – | -$130K | -84,790 | Closed |
|
62
Two Sigma Investments
New York
| – | -$67.8K | -44,328 | Closed |
|
|
TRCT
63
Tower Research Capital (TRC)
New York
| – | -$3.5K | -2,284 | Closed |
|
STXS Hedge Fund Activity: Q3 2023 in Review
58 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q3 2023, worth a combined $59.9M — down 2% from $61.1M a quarter earlier.
Fund positioning in STXS was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 17 added to existing stakes and 18 trimmed.
The largest buyer was Archon Capital Management, adding an estimated $358K. The largest seller was Opaleye Management, exiting entirely with an estimated $2.95M sold.
- 58 institutional investors held Stereotaxis (STXS) as of Q3 2023, down from 59 in Q2 2023.
- Funds reported $59.9M of Stereotaxis stock for Q3 2023, down 2% quarter-over-quarter.
- 5 funds opened new Stereotaxis positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest Stereotaxis buyer in Q3 2023 was Archon Capital Management, an estimated $358K added.
- The largest Stereotaxis seller in Q3 2023 was Opaleye Management, an estimated $2.95M sold.
Based on aggregated 13F filings for Q3 2023.